Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Somers

Showing results (201-210 of 208) with videos related to

Pageof 21
Sort By:
You have reached the last page of results.This site can display upto 208 results.
Nature Medicine|July 17, 2025
Clinical utility of targeted RNA sequencing in cancer molecular diagnosticsRobert Siddaway, Aida I Glembocki, Anthony Arnoldo, et al.
Nature Genetics|September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaC Graux, J Cools, C Melotte, et al.
Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.
American Journal of Human Genetics|December 7, 2015
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous DysplasiaMary J Gray, Peter Kannu, Swarkar Sharma, et al.
Science (New York, N.Y.)|September 1, 2018
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumorsNathaniel D Anderson, Richard de Borja, Matthew D Young, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 21

Showing results (201-210 of 208) with videos related to

Sort By:
Pageof 21
You have reached the last page of results.This site can display upto 208 results.
Nature Medicine|July 17, 2025
Clinical utility of targeted RNA sequencing in cancer molecular diagnosticsRobert Siddaway, Aida I Glembocki, Anthony Arnoldo, et al.
Nature Genetics|September 14, 2004
Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemiaC Graux, J Cools, C Melotte, et al.
Nature Communications|January 5, 2023
Germline TP53 mutations undergo copy number gain years prior to tumor diagnosisNicholas Light, Mehdi Layeghifard, Ayush Attery, et al.
American Journal of Human Genetics|December 7, 2015
Mutations Preventing Regulated Exon Skipping in MET Cause Osteofibrous DysplasiaMary J Gray, Peter Kannu, Swarkar Sharma, et al.
Science (New York, N.Y.)|September 1, 2018
Rearrangement bursts generate canonical gene fusions in bone and soft tissue tumorsNathaniel D Anderson, Richard de Borja, Matthew D Young, et al.
Nature Cancer|December 30, 2022
The clinical utility of integrative genomics in childhood cancer extends beyond targetable mutationsAnita Villani, Scott Davidson, Nisha Kanwar, et al.
The Lancet. Oncology|April 18, 2015
Molecular subgroups of atypical teratoid rhabdoid tumours in children: an integrated genomic and clinicopathological analysisJonathon Torchia, Daniel Picard, Lucie Lafay-Cousin, et al.
Cancer Cell|December 14, 2016
Integrated (epi)-Genomic Analyses Identify Subgroup-Specific Therapeutic Targets in CNS Rhabdoid TumorsJonathon Torchia, Brian Golbourn, Shengrui Feng, et al.
Pageof 21